MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Industry news

Alfacell Corporation Announces Closing of $3.25 Million Private Placement

In order to access this content you must be logged in and have a subscription to PL Intelligence.

PLi

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits PL Intelligence has to offer. Find out more.

Company details

If you want to find out more about the company visit Alfacell profile.

Related news

Latest News

NOVELOS THERAPEUTICS CLOSES LAST TRANCHE IN $9 MILLION PRIVATE PLACEMENT
BIOVEX COMPLETES $70 MILLION FINANCING TO CONCLUDE PIVOTAL STUDY WITH ITS PIONEERING CANCER TREATMENT, ONCOVEXGM-CSF
Phase Forward Announces Share Repurchase Program
Veeco Completes Common Stock Offering
Oncolytics Biotech
ART Secures up to $1.2 Million in Interim Financing in Connection with the Pursuit of its Strategic Review Process and Files a Notice of Intention Under the Bankruptcy and Insolvency Act
PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal Cancer Patients to Benefit from State-of-the-Art RapidArc and Novalis Tx Installations
CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises
St. Jude Medical Board of Directors Authorizes Share Repurchase
More news... | RSS Feed...

Most Viewed

PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.

CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises

Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal Cancer Patients to Benefit from State-of-the-Art RapidArc and Novalis Tx...

Alfacell Corporation Announces Closing of $3.25 Million Private Placement

Phase Forward Announces Share Repurchase Program

AGA Medical Holdings, Inc. Announces Pricing of its Initial Public Offering

BIOVEX COMPLETES $70 MILLION FINANCING TO CONCLUDE PIVOTAL STUDY WITH ITS PIONEERING CANCER TREATMENT, ONCOVEXGM-CSF

St. Jude Medical Board of Directors Authorizes Share Repurchase

MedaSorb Technologies Corporation Raises $1.3M in Series B Warrant Exercise

COLUMBIA LABORATORIES ANNOUNCES REGISTERED DIRECT COMMON STOCK OFFERING

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
PharmaVenue
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us